Literature DB >> 1736850

Brain-stem auditory evoked potentials in human immunodeficiency virus-seropositive patients with and without acquired immunodeficiency syndrome.

M A Pagano1, P E Cahn, M L Garau, C A Mangone, H A Figini, A A Yorio, M C Dellepiane, M G Amores, H M Perez, A D Casiró.   

Abstract

Brain-stem auditory evoked potentials were recorded in 35 human immunodeficiency virus (HIV)-seropositive subjects from the Centers for Disease Control groups III and IV, 24 HIV-negative drug abusers, and 62 normal healthy controls. None of the patients had evidence of neurological complications. History of alcohol consumption was an exclusion criterion. The values of central conduction times I-V and III-V showed significant differences between the HIV-seropositive subjects and normal healthy controls, as well as between the HIV-seropositive subjects and HIV-negative drug abusers. Central conduction times I-III showed no differences between groups, except in the left ear of Centers for Disease Control group IV compared with controls. No statistical differences were found in the central conduction times between HIV-negative drug abusers and normal healthy controls. The results suggest a subclinical involvement of the upper brain stem in HIV infection. It could be produced by direct action of the virus on central nervous system structures.

Entities:  

Mesh:

Year:  1992        PMID: 1736850     DOI: 10.1001/archneur.1992.00530260068022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.

Authors:  Hyejeong Hong; David W Dowdy; Kelly E Dooley; Howard W Francis; Chakra Budhathoki; Hae-Ra Han; Jason E Farley
Journal:  Am J Audiol       Date:  2020-04-22       Impact factor: 1.493

2.  Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.

Authors:  Landhing M Moran; Michael Y Aksenov; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  WEBER'S SYNDROME DUE TO CEREBRAL TOXOPLASMOSIS.

Authors:  H Madan; N Kumar; Rajat Kumar; M M Singh
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.

Authors:  Eleanor S Roberts; Salvador Huitron-Resendiz; Michael A Taffe; Maria Cecilia G Marcondes; Claudia T Flynn; Caroline M Lanigan; Jennifer A Hammond; Steven R Head; Steven J Henriksen; Howard S Fox
Journal:  J Neurosci       Date:  2006-04-26       Impact factor: 6.167

5.  Auditory impairments in HIV-infected individuals in Tanzania.

Authors:  Isaac I Maro; Ndeserua Moshi; Odile H Clavier; Todd A MacKenzie; Robert J Kline-Schoder; Jed C Wilbur; Robert D Chambers; Abigail M Fellows; Benjamin G Jastrzembski; John E Mascari; Muhammad Bakari; Mecky Matee; Frank E Musiek; Richard D Waddell; C Fordham von Reyn; Jay C Buckey
Journal:  Ear Hear       Date:  2014 May-Jun       Impact factor: 3.570

Review 6.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

Review 7.  Recent advances in the neurology of HIV infection.

Authors:  R K Petty
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

8.  Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction.

Authors:  L M Moran; R M Booze; K M Webb; C F Mactutus
Journal:  Exp Neurol       Date:  2012-10-11       Impact factor: 5.330

9.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

10.  Early physiological abnormalities after simian immunodeficiency virus infection.

Authors:  T F Horn; S Huitron-Resendiz; M R Weed; S J Henriksen; H S Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.